A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Progress in Biophysics and Molecular Biology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PBIOMOLBIO.2007.10.001PMID 18076975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotection for ischemic stroke: Two decades of success and failure

  2011cited by this paper
• Progress in Biophysics and Molecular Biology

  2010cited by this paper
• 引言 (Introduction)

  2009cited by this paper
• Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. (1992).

  2008cited by this paper
• [Thrombolytic therapy for acute ischemic stroke].

  2006cited by this paper
• A mathematical model of ion movements in grey matter during a stroke.

  2006cited by this paper
• Stroke and neurovascular protection.

  2006cited by this paper
• Challenges of Neuroprotection and Neurorestoration in Ischemic Stroke Treatment

  2005cited by this paper
• The expanding TOR signaling network.

  2005cited by this paper
• Is White Matter Involved in Patients Entered into Typical Trials of Neuroprotection?

  2005influential reference
• White matter injury mechanisms.

  2004cited by this paper
• Lost in translation: taking neuroprotection from animal models to clinical trials

  2004cited by this paper
• Mathematical Modelling of an Ischemic Stroke: An Integrative Approach

  2004cited by this paper
• Thrombolytic therapy in acute ischemic stroke

  2003cited by this paper
• Astrocytes and Stroke: Networking for Survival?

  2003cited by this paper
• Astrocytes and Brain Injury

  2003cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Acute Ischemic Stroke Treatment: An Emergency B. Therapy

  2003cited by this paper
• Oligodendrocytes and Ischemic Brain Injury

  2003cited by this paper
• [Cerebral ischemia--challenges and perspectives].

  2002cited by this paper
• Salvaging The Ischaemic Penumbra: More Than Just Reperfusion?

  2002cited by this paper
• Physiologically Based Model of Acute Ischemic Stroke

  2002cited by this paper
• Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions

  2002cited by this paper
• Very early nimodipine use in stroke (VENUS): A randomized, double-blind, placebo-controlled trial.:

  2001influential reference
• Acute Ischemic Stroke Treatment: State of the Art and New Options

  2001cited by this paper
• Acute Ischemic Stroke Treatment: State of the Art and New Options

  2001cited by this paper
• Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.

  2001influential reference
• Neuroprotection for Ischaemic Stroke

  2001influential reference
• Ionic Mechanisms of Aglycemic Axon Injury in Mammalian Central White Matter

  2001cited by this paper
• Use of anti-ICAM-1 therapy in ischemic stroke

  2001cited by this paper
• The value of apparent diffusion coefficient maps in early cerebral ischemia.

  2001cited by this paper
• Understanding and managing ischemic stroke.

  2001cited by this paper
• Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion of water.

  2001cited by this paper
• Neuroprotection.

  2000cited by this paper
• Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.

  2000influential reference
• Lubeluzole in Acute Ischemic Stroke Treatment: A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo

  2000influential reference
• Ion channels in glial cells.

  2000cited by this paper
• NMDA Receptor Blockade Fails to Alter Axonal Injury in Focal Cerebral Ischemia

  2000cited by this paper
• Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

  1999cited by this paper
• Drug development for stroke: importance of protecting cerebral white matter.

  1999influential reference
• Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

  1999cited by this paper
• Biochemical and Molecular Characteristics of the Brain with Developing Cerebral Infarction

  1999cited by this paper
• Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve.

  1999cited by this paper
• The ischemic penumbra: operationally defined by diffusion and perfusion MRI.

  1999cited by this paper
• Failure of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials

  1999cited by this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke

  1999influential reference
• White matter ischaemia.

  1999cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999influential reference
• Ca2+ channel antagonists and neuroprotection from cerebral ischemia.

  1998cited by this paper
• A model for the regulation of cerebral oxygen delivery.

  1998cited by this paper
• Intravenous t‐PA for acute ischemic stroke

  1998cited by this paper
• Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics

  1998influential reference
• Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons.

  1997cited by this paper
• Protection with lubeluzole against delayed ischemic brain damage in rats. A quantitative histopathologic study.

  1997cited by this paper
• Flunarizine in stroke treatment (FIST): a double‐blind, placebo‐controlled trial in Scandinavia and the Netherlands

  1996influential reference
• A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.

  1996cited by this paper
• Emerging treatments for stroke in humans.

  1996cited by this paper
• News on glutamate receptors in glial cells.

  1996cited by this paper
• Safety, Tolerability, and Pharmacokinetics of the N-Methyl-d-Aspartate Antagonist Dextrorphan in Patients With Acute Stroke

  1995influential reference
• Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group.

  1995influential reference
• Evolution of Regional Changes in Apparent Diffusion Coefficient during Focal Ischemia of Rat Brain: The Relationship of Quantitative Diffusion NMR Imaging to Reduction in Cerebral Blood Flow and Metabolic Disturbances

  1995cited by this paper
• Comparison of diffusion‐weighted MRI with changes in cell volume in a rat model of brain injury

  1994cited by this paper
• Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents.

  1994cited by this paper
• Pathophysiology and treatment of acute ischemic stroke.

  1993cited by this paper
• Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion‐weighted echo‐planar imaging

  1993influential reference
• Pathophysiology and treatment of acute ischemic stroke.

  1993cited by this paper
• [Protective action of phenytoin on cerebral ischemia in rats].

  1992cited by this paper
• Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology.

  1992cited by this paper
• Epidemiology of stroke.

  1992cited by this paper
• Role of Na/K/Cl cotransport in astrocytes.

  1992cited by this paper
• Astrocytes, as well as neurons, express a diversity of ion channels.

  1992cited by this paper
• Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment.

  1992cited by this paper
• Regional variation of extracellular space in the hippocampus.

  1990cited by this paper
• Nimodipine Improves Cerebral Blood Flow and Neurologic Recovery after Complete Cerebral Ischemia in the Dog

  1983cited by this paper
• Thresholds in cerebral ischemia - the ischemic penumbra.

  1981cited by this paper
• The epidemiology of stroke.

  1979cited by this paper

• Systems-level computational modeling in ischemic stroke: from cells to patients

  2024cites this paper
• Empirical methods for the validation of time-to-event mathematical models taking into account uncertainty and variability: application to EGFR + lung adenocarcinoma

  2023cites this paper
• Predictive validity in drug discovery: what it is, why it matters and how to improve it

  2022cites this paper
• Neuroprotective Treatment of Postanoxic Encephalopathy: A Review of Clinical Evidence

  2021cites this paper
• Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms

  2017cites this paper
• Fonction plaquettaire et altération de l’hémostase après hémorragie sous arachnoïdienne

  2017cites this paper
• Fisiopatologia dell’ischemia cerebrale

  2015cites this paper
• Bridging Systems Medicine and Patient Needs

  2015cites this paper
• Oligodendrocyte Pathophysiology and Treatment Strategies in Cerebral Ischemia

  2014cites this paper
• How does spreading depression spread? Physiology and modeling

  2014cites this paper
• Physiopathologie de l’ischémie cérébrale

  2014cites this paper
• Biotherapies in stroke.

  2014cites this paper
• Biotherapies dans l'accident vasculaire cerebral

  2014cites this paper
• Neuronal activity and ion homeostasis in the hypoxic brain

  2014cites this paper
• Neuroprotection for Ischemic Stroke: Moving Past Shortcomings and Identifying Promising Directions

  2013cites this paper
• Lessons in Modeling, Preventing, and Treating Neural Injury: Improving Bench-to- Bedside Translation

  2013cites this paper
• Effect Model Law: An Approach for the Implementation of Personalized Medicine

  2013cites this paper
• Age and the Metabolic Syndrome as Risk Factors for Ischemic Stroke: Improving Preclinical Models of Ischemic Stroke

  2012cites this paper
• Traveling fronts guided by the environment for reaction-diffusion equations

  2012cites this paper
• Adaptive numerical methods in time and space for the simulation of multi-scale reaction fronts. (Méthodes numériques adaptatives pour la simulation de la dynamique de fronts de réaction multi-échelles en temps et en espace)

  2011cites this paper
• Regulation of caspases in the nervous system implications for functions in health and disease.

  2011cites this paper
• Simulation of human ischemic stroke in realistic 3D geometry

  2010cites this paper
• Recent findings in kynurenine research in the field of experimental epilepsy and stroke models : Electrophysiological, behavioural and histological studies

  2009cites this paper
• MODÉLISATION DES DÉPRESSIONS CORTICALES ENVAHISSANTES ET EXISTENCE DE FRONTS PROGRESSIFS

  2009cites this paper
• Brain Poster Session: Experimental Stroke and Cerebral Ischemia

  2009cites this paper
• L-kynurenine: Metabolism and mechanism of neuroprotection

  2008cites this paper
• Modelling methodology in physiopathology.

  2008cites this paper
• Mechanisms of neuronal death in disease: defining the models and the players.

  2008cites this paper